LaserSight's ADK
This article was originally published in The Gray Sheet
Executive Summary
Orlando, Florida-based firm's automated disposable keratome device will be incorporated sometime this year into CRS Clinical Research's study on laser in-situ keratomileusis (LASIK) for treatment of myopia, astigmatism and hyperopia, the firm reports March 24. LaserSight claims the study, which encompasses more than 250 surgeons, represents the largest U.S. trial ever conducted under an FDA-approved IDE. Keratomes are surgical tools used to create a thin corneal flap during refractive surgery
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.